Hatch Medical receives two US patents for percutaneous spinal stabilization system

Medical device incubator and technology brokerage firm, Hatch Medical, L.L.C. today announced the issuance of US Patent No. 8,357,197 and US Patent No. 8,357,198 related to their percutaneous spinal stabilization system. Hatch Medical previously entered into a joint venture with physician inventor J. Kevin McGraw, M.D. to develop and market the "microinvasive" spinal stabilization technology to the medical device industry.

“The issuance of these patents is a supportive step in the evolution of next generation spinal stabilization devices”

A published author, editor and noted lecturer on interventional radiological procedures of the spine, Dr. McGraw's proprietary technology and design elements provide a minimally invasive means to stabilize adjacent vertebrae while preserving patient mobility. The system involves an image-guided, 10 gauge percutaneous placement of a series of curved stabilization rods cross-linking adjacent vertebrae. "We believe our percutaneous system will provide an effective alternative to treat discogenic back pain," commented physician inventor J. Kevin McGraw. "Our system permits a fast, efficacious and cost effective option to stabilize and support the targeted region," added Dr. McGraw.

The development of percutaneous, minimally invasive spinal procedures has yielded major improvements in reducing recovery time and postoperative pain. "The issuance of these patents is a supportive step in the evolution of next generation spinal stabilization devices," commented Steven Hvozda, a Principal member of Hatch Medical. "We're excited to move aggressively forward with the implementation of our market strategy," added Mr. Hvozda.

Source:

Hatch Medical, L.L.C.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Squid-inspired technology could replace needles for medications and vaccines